Four Seasons Ventures has built an investment team that draws from diverse experiences in engineering, politics, operations, executive management, banking, investment research, and venture capital. We strive to be a trusted partner to our portfolio companies.
Michael Goldblatt’s expertise lies in the identification and commercial development of early stage technologies including engineering, design, manufacturing and distribution. His experience pioneering next generation technologies including femto-second lasers, advanced ultraviolet systems, nickel-zinc batteries, meta-materials, and therapeutic proteins supports this focus.
Michael J. Goldblatt, Ph.D., J.D., is also the President and Chief Executive Officer of Functional Genetics, a clinical stage biotech company. Dr. Goldblatt joined Functional Genetics, Inc. in 2003 after his appointment as Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA). Part of Dr. Goldblatt’s DARPA responsibilities included creating the foundational efforts to make biology a future historical strength for the Department of Defense. This included programmatic thrusts in defending against biological threats, leveraging biology to enhance defense systems and enhancing human performance. Prior to his work with the Department of Defense, Dr. Goldblatt was the Science and Technology officer for McDonald's Corporation with broad responsibilities, including nutrition, product development, food safety and corporate venture capital. Before joining McDonald’s Corporation, Dr. Goldblatt was Director of Scientific and Regulatory Affairs at General Foods Corporation. Dr. Goldblatt holds a J.D., Ph.D. from the University of California at Davis and a B.A. in Biology from Reed College. Dr. Goldblatt is admitted to practice law by the Washington DC, New York and U.S. Patent Bars.